Media & Investors

Press Releases

2014.04.11 Corporate PDF(118KB)
Announcement Regarding Merger Between Sun Pharma and Daiichi Sankyo’s Subsidiary Ranbaxy and Resulting Change in Subsidiary
2014.04.07 Corporate PDF(25KB)
Daiichi Sankyo Agrees to Vote its Shares in Ranbaxy in Favor of Sun Pharma’s Acquisition
2014.04.07 Corporate PDF(20KB)
Subpoena for Ranbaxy’s Toansa Plant
2014.04.03 R&D PDF(31KB)
Daiichi Sankyo and UC San Francisco Announce Collaboration in Drug Discovery Research for Neurodegenerative Diseases
2014.04.01 R&D PDF(50KB)
Daiichi Sankyo Initiates Phase 3 ENSURE-AF Study, Investigating Once-Daily Edoxaban in Patients with Atrial Fibrillation Undergoing Cardioversion
2014.03.31 Local (JPN) PDF(18KB)
Daiichi Sankyo Medical Representatives Improve Life-saving Knowledge and Skills
2014.03.25 Local (JPN) PDF(52KB)
Daiichi Sankyo to Facilitate New Drug Discovery in 2014 through Collaborative Research and Grants
2014.03.24 Local (JPN) PDF(47KB)
Daiichi Sankyo Receives Approval in Japan for Manufacturing and Marketing of the Antiplatelet Agent Efient® 3.75mg/5mg Tablets
2014.03.24 Local (JPN) PDF(46KB)
Subgroup Analysis of PRASFIT-ACS Study Evaluated Impact of Platelet Reactivity on Prevention of Ischemic Events in Perioperative Period of PCI
2014.03.24 R&D PDF(98KB)
Once-Daily Edoxaban Evaluated in Two Subgroup Analyses of East Asian Patients from the Largest Comparative Phase 3 Trials of a Novel Oral Anticoagulant
2014.03.19 R&D PDF(77KB)
Astellas Pharma and Daiichi Sankyo Form Compound Library Sharing Partnership
2014.03.17 Local (JPN) PDF(16KB)
Daiichi Sankyo Files NDA in Japan for Methaemoglobinaemia Injection Methylene Blue
2014.03.06 Local (JPN) PDF(89KB)
Announcement Regarding the Project of H5N1 Influenza Vaccines
2014.03.03 Corporate PDF(42KB)
Daiichi Sankyo Announces Organizational Restructuring as of April 1, 2014
2014.03.03 Corporate PDF(75KB)
Daiichi Sankyo Appoints New Group Corporate Officers
2014.02.25 Corporate PDF(16KB)
Updates on Toansa and Dewas plants of Ranbaxy
2014.02.14 R&D PDF(207KB)
Daiichi Sankyo and UMN Pharma Enter into Collaborative Research Agreement for Norovirus Vaccine
2014.02.06 IR PDF(110KB)
Ranbaxy Q4 FY14 Sales Rs.28.6 Bn. YTD Dec 2013 Sales Rs.106.0 Bn.
2014.01.31 IR PDF(99KB)
Voluntary Adoption of International Financial Reporting Standards (IFRS)
2014.01.24 Corporate PDF(17KB)
Update on Regarding the Import Alert on Ranbaxy’s Toansa Plant
2014.01.24 Corporate PDF(10KB)
Regarding the Import Alert on Ranbaxy’s Toansa Plant
2014.01.14 Corporate PDF(12KB)
Regarding Ranbaxy’s Toansa Plant
2014.01.09 R&D PDF(53KB)
Daiichi Sankyo, Virtici and Celdara Medical Announce Collaboration to Identify and Progress High Potential Therapeutics
2014.01.09 R&D PDF(47KB)
Daiichi Sankyo Submits SAVAYSA(TM) (edoxaban) Tablets New Drug Application to the U.S. FDA for Once-Daily Use for Stroke Risk Reduction in Atrial Fibrillation and for the Treatment and Prevention of Recurrence of Venous Thromboembolism
2014.01.08 R&D PDF(65KB)
Daiichi Sankyo Submits Edoxaban Marketing Authorization Application to the EMA for Once-Daily Use for Stroke Prevention in Atrial Fibrillation and for the Treatment and Prevention of Recurrence of Venous Thromboembolism